NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-228-2016-1-SG-12 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof SG National Stage 11201901790Y Abandoned
NCI E-040-2012-0-US-24 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 15/692,473 10767184 Issued PDF
NICHD E-010-2010-0-US-05 Method For The Detecting Hematoma, Portable Detection and Discrimination Device and Related Systems and Apparatuses US CON 15/691,661 11800983 Issued PDF
NIAID E-238-2012-1-CA-05 HIV Inhibitors CA National Stage 2845933 Issued
NCI E-062-2019-3-US-01 Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate US 62/552,296 Expired
NCI E-148-2011-0-IL-14 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IL DIV 254201 Issued
NCI E-267-2016-0-EP-04 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases EP National Stage 16749945.8 Issued
NIAID E-168-2016-0-PCT-02 METHOD AND COMPOSITION FOR OPTICAL CLEARING OF TISSUES PCT PCT PCT/US2017/049133 Expired
NCI E-168-2017-0-US-01 RADIOLIGAND FOR ASSESSING HUMAN TRPV1 STRUCTURE-ACTIVITY RELATIONSHIPS AND METHOD OF USE US 62/551,436 Abandoned
NCATS E-232-2017-0-US-01 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders US 62/550,826 Abandoned
NCI E-214-2016-0-PCT-02 HUMAN SINGLE DOMAIN ANTIBODIES TARGETING CD16A TO MEDIATE ADCC PCT PCT PCT/US2017/048721 Abandoned
NHLBI E-211-2018-1-US-01 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US 62/550,253 Abandoned
NHLBI E-222-2022-0-US-01 Multi Lumen Independently Deflectable Catheter US 62/550,347 Expired
NIA E-012-2012-0-CA-04 COMBINATION THERAPY USING IMMUNOGLOBULIN AND C1-INHIBITOR CA National Stage 2848510 Pending
NHGRI E-092-2014-1-US-05 SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS US National Stage 15/553,561 10493087 Abandoned PDF
NIAID E-239-2014-0-US-06 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US National Stage 15/553,466 10301377 Issued PDF
NIAMS E-189-2017-0-US-01 Regulatory Genetic Variants of IL1RN US 62/549,746 Abandoned
NCI E-143-2017-0-US-01 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range US 62/549,566 Abandoned
NCI E-230-2012-0-AU-12 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AU DIV 2017219019 Issued
NIAID E-236-2018-0-KR-01 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof KR ORD 10-2017-0106836 Issued
NIBIB E-006-2016-0-PCT-02 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy PCT PCT PCT/US2017/048234 Expired
NIBIB E-006-2016-0-CN-05 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy CN National Stage 201780030158.5 Abandoned
NCI E-021-2018-0-PCT-02 INSTRUMENTED BIOPSY PROBE PCT PCT PCT/US2017/048047 Expired
NCI E-021-2018-0-US-03 INSTRUMENTED BIOPSY PROBE US ORD 15/683,381 Abandoned
NEI E-165-2017-0-US-01 Compositions and Methods To Protect Mammalian Tissue Against Cold And Other Metabolic Stresses US 62/547,945 Abandoned
NIAID E-239-2014-0-SA-05 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE SA National Stage 517382168 Abandoned
NIDDK E-225-2017-0-US-01 PEPTIDE NUCLEIC ACID-COATED GOLD NANOPARTICLES FOR SIGNAL DETECTION AND AMPLIFICATION IN MICROFLUIDIC DIAGNOSTICS US 62/547,489 Abandoned
NCI E-344-2013-0-US-10 TEM8 Antibodies and Their Use in Treatment and Detection of Tumors US CON 15/680,177 10196443 Issued PDF
NHLBI E-175-2017-0-US-01 Hybrid CT System With Additional Detectors In Close Proximity To The Body US 62/546,639 Abandoned
NCATS E-262-2016-0-EP-03 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS EP National Stage 17821743.6 Abandoned
NCATS E-262-2016-0-GB-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS GB EP 17821743.6 Abandoned
NCATS E-262-2016-0-NO-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS NO EP 17821743.6 Abandoned
NCATS E-262-2016-0-PT-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS PT EP 17821743.6 Abandoned
NCATS E-262-2016-0-PL-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS PL EP 17821743.6 Abandoned
NCATS E-262-2016-0-NL-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS NL EP 17821743.6 Abandoned
NCATS E-262-2016-0-BE-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS BE EP 17821743.6 Abandoned
NCATS E-262-2016-0-AT-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS AT EP 17821743.6 Abandoned
NCATS E-262-2016-0-IE-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS IE EP 17821743.6 Abandoned
NCATS E-262-2016-0-DE-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS DE EP 17821743.6 Abandoned
NCATS E-262-2016-0-LV-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS LV EP 17821743.6 Abandoned
NCATS E-262-2016-0-LT-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS LT EP 17821743.6 Abandoned
NCATS E-262-2016-0-IT-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS IT EP 17821743.6 Abandoned
NCATS E-262-2016-0-LU-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS LU EP 17821743.6 Abandoned
NCATS E-262-2016-0-DK-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS DK EP 17821743.6 Abandoned
NCATS E-262-2016-0-FI-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS FI EP 17821743.6 Abandoned
NCATS E-262-2016-0-FR-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS FR EP 17821743.6 Abandoned
NCATS E-262-2016-0-TR-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS TR EP 17821743.6 Abandoned
NCATS E-262-2016-0-CH-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS CH EP 17821743.6 Abandoned
NCATS E-262-2016-0-SE-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS SE EP 17821743.6 Abandoned
NCATS E-262-2016-0-ES-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS ES EP 17821743.6 Abandoned